Not recruiting
Cardiac failure
Not recruitingA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
Investigational
A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
Investigational
- Disease:Cardiac failure
- Substances:Ziltivekimab
Countries:
Latvia
Latvia- Participants:18–64 years · 65+ years
- Substances:Ziltivekimab
- Sponsor:Novo Nordisk A/S



